Save the Date & Call for Presenters: Cell Based Assays & BioAnalytical Method Development 2010

In 2010, we are combining the Cell Based Assays and Bioanalytical Development Conferences to provide one comprehensive event that encompasses both areas, yet leaving time to dive deeply into the content of each one using separate track sessions. It will take place October 4-6, 2010 in San Francisco, California

Visit the Cell Based Assays website for further updates!
http://bit.ly/dc8frZ

Would you like to be a presenter at Cell Based Assays or Bioanalytical Development?
We invite you to submit a proposal for a speaking opportunity directly to Anne Reel, Senior Conference Director, by April 23rd, 2010 at the very latest. Send to areel@iirusa.com or call 919-676-0306.

Submission Guidelines & Details

We expect that the conference will attract between 75-125 attendees. For consideration, please e-mail areel@iirusa.com with the following information by April 23, 2010

• Proposed speaker name(s), job title(s), and company name(s)
• Contact information including address, telephone number, and e-mail
• Title and objective of presentation
• Please indicate which topic you plan to address.
• Short Summary of the talk

We are also interested in proposals for one day and half day workshops. These workshops should be focused on specific techniques and skill building topics.

All speakers receive FREE admission to the conference as well as any pre-conference activities

General Areas
• Potency
• Immunogenicity
• Characterization
• In Vitro Toxicology
• Immunotoxicolgy
• Fc Functionality
• ADCC Assays

Case Studies Suggestions:
• Fc gamma binding ADCC, FC effecter binding and function, Assessment of FC functionality and F binding ADCC
• Alternative assays to using ADCC to measure FC/FCR binding
• ADC matrix interference
• QA Assays development & QC assay qualification
• Antiviral reporter assay
• Cell based functional assays
• Technical Platform qualification and evaluate long term usefulness of new technologies
• How to rapidly develop assays for new indication where there is no established systems
• Determine limit of detection of assay and complexity of MoA
• Case studies on cell based potency assays, methodology selection cellular mechanisms
• Strategies for characterizing new therapeutics for efficacy
• Improvements in innovation and automation
• Surrogate for NK cells –example NK cell line
• Antibody drug conjugate case studies
• Total and bound assays-free vs total drug assays examples
• Technologies to measure drug target interactions

Why should you attend?
• To learn from other in industry how they overcome issues
• To update recent research analysis and methods development
• To gain insight into the state of the art bioanalytical methods
• To learn where BA field in respect to measuring total vs free drug target in pre clinical and clinical studies

Is your number one challenge not addressed here?
Contact Anne Reel to ensure it is on the final program! AReel@iirusa.com

Do you want to reach this audience?
We have a limited number of slots available for solution providers/consultants.
People who wish to become part of the program should contact Dave Borrok, Sponsorship Manager, at 646.895.7485 or dborrok@iirusa.com.

This year, BioAnalytical Method Development be co-located with Cell Based Assays. To find out more about BioAnalytical Method Development, visit the webpage: http://bit.ly/dc8frZ

Share this article with your social network, just click below to share now!

Share |